InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,218.81
(
0.09%
)
US TECH 100
17,661.00
(
0.11%
)
Dow Jones
39,497.83
(
0.28%
)
Brent Oil
82.79
(
-1.39%
)
Bitcoin
61,013.30
(
-3.23%
)
Post# of 3309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

naturalborninvestor

Send PM Follow Ignore
Followers 184
Posts 19312
Boards Moderated 0
Alias Born 03/07/2009

naturalborninvestor

Re: naturalborninvestor post# 1095

Monday, 09/11/2017 4:50:00 PM

Monday, September 11, 2017 4:50:00 PM

Post# of 3309
nice day. Expecting positive phase 1 results from CC (not phase 2 as I said earlier). Topical Endoxifen has the potential to radically change breast cancer treatment. $10 billion market!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ATOS News
More ATOS News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!